Literature DB >> 24742537

High prevalence of hepatitis B non-immunity in paediatric non-alcoholic fatty liver disease patients.

Minesh Mehta1, Crystal Slaughter2, Stavra A Xanthakos2, Rohit Kohli2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24742537      PMCID: PMC4300100          DOI: 10.1016/j.dld.2014.03.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  4 in total

1.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

2.  Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.

Authors:  D J Weber; W A Rutala; G P Samsa; J E Santimaw; S M Lemon
Journal:  JAMA       Date:  1985-12-13       Impact factor: 56.272

3.  Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination.

Authors:  J Simó Miñana; M Gaztambide Ganuza; P Fernández Millán; M Peña Fernández
Journal:  Vaccine       Date:  1996-02       Impact factor: 3.641

4.  A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD.

Authors:  Stephanie DeVore; Rohit Kohli; Kathleen Lake; Lynda Nicholas; Kim Dietrich; William F Balistreri; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

  4 in total
  2 in total

1.  Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.

Authors:  Kyeong Hun Lee; Kyu Seok Shim; In Seok Lim; Soo Ahn Chae; Sin Weon Yun; Na Mi Lee; Young Bae Choi; Dae Yong Yi
Journal:  BMC Pediatr       Date:  2017-07-14       Impact factor: 2.125

Review 2.  PCAF fine-tunes hepatic metabolic syndrome, inflammatory disease, and cancer.

Authors:  Tongxin Wang; Weilei Yao; Yafei Shao; Ruilong Zheng; Feiruo Huang
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.